Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation of the C-mo System - Cough Monitoring

NCT: NCT05989698 · RECRUITING

NCT IDNCT05989698
StatusRECRUITING
Start Date2023-12-11
Completion2026-09

Brief Summary

The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory symptom. The main questions it aims to answer are: 1. Can C-mo System detect cough events? (automatic cough detection) 2. Can C-mo System characterise cough events? (calculation of cough intensity, identification of cough type and presence of wheeze in detected coughs) Participants will be asked to: * Wear the C-mo Wearable device for 24 hours (1 day); * Complete a diary with relevant activities throughout the monitoring period; * Fill-out questionnaires related to coughing frequency and intensity, usability of the device, and impact of cough on quality of life.

Frequently Asked Questions

What is Validation of the C-mo System - Cough Monitoring?

Validation of the C-mo System - Cough Monitoring is a clinical trial registered under NCT05989698. Current status: RECRUITING.

What is the status of NCT05989698?

The current status of NCT05989698 (Validation of the C-mo System - Cough Monitoring) is: RECRUITING.

When did Validation of the C-mo System - Cough Monitoring start?

Validation of the C-mo System - Cough Monitoring started on 2023-12-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.